Obesity and Reversed Growth Retardation in a Child with Type Ia Glycogen Storage Disease

被引:6
|
作者
Karnsakul, Wikrom [1 ,2 ]
Gillespie, Stacey [2 ]
Skitarelic, Kathryn
Hummel, Marybeth [2 ]
机构
[1] Johns Hopkins Univ, Sch Med, Div Pediat Gastroenterol & Nutr, Baltimore, MD 21218 USA
[2] W Virginia Univ, Sch Med, Robert C Byrd Hlth Sci Ctr, Dept Pediat, Morgantown, WV 26506 USA
来源
关键词
glycogen storage disease type 1; obesity; insulin resistance; reversed growth retardation; hepatic steatosis; 1A; LIPOPROTEINS;
D O I
10.1515/jpem.2010.083
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Type Ia Glycogen storage disease is an autosomal recessive hepatic metabolic disease due to a lack of glucose-6-phosphatase (G-6-Pase) activity presenting with growth retardation, lactic acidosis, fasting hypoglycemia with hypoinsulinemia, hyperuricemia, hepatomegaly, and hepatic adenoma with a risk of malignancy. The gene that encodes G-6-Pase was mapped to 17q21. There are some genotype-phenotype correlations. We report a case with delF327 mutation which is devoid of G-6-Pase activity; however clinical presentation in this case differs somewhat. Although correction of hypoglycemia and lactic acidosis with nocturnal intragastric feeding and uncooked starch therapy improves growth failure, mean height of the patients is often less than the target. Normal height and obesity in this case with hepatic steatosis and low hepatic glycogen storage requires clinical reevaluation since there are some overlapping phenotypes between type Ia GSD and metabolic syndrome. The phenomenon may be related to insulin resistance as a consequence of early aggressive nutrition therapy with frequent low glycemic index meals.
引用
收藏
页码:507 / 512
页数:6
相关论文
共 50 条
  • [31] Estimation of Health Utility Scores for Glycogen Storage Disease Type Ia
    Kruger, Eliza
    Aggio, Daniel
    de Freitas, Hayley
    Lloyd, Andrew
    PHARMACOECONOMICS-OPEN, 2023, 7 (04) : 627 - 638
  • [32] Case of cholangiocellular carcinoma in a patient with glycogen storage disease type Ia
    Kanamori, Hiroyuki
    Nakade, Yukiomi
    Yamamoto, Takaya
    Kobayashi, Yuji
    Sato, Ken
    Ito, Kiyoaki
    Ohashi, Tomohiko
    Nakao, Noiku
    Ishii, Norimitsu
    Takahashi, Emiko
    Yokoi, Toyoharu
    Nakao, Haruhisa
    Kurokawa, Tsuyoshi
    Yamaguchi, Chikara
    Yoneda, Masashi
    HEPATOLOGY RESEARCH, 2015, 45 (04) : 494 - 499
  • [33] Glycogen storage disease type Ia: molecular study in Brazilian patients
    Reis, FD
    Caldas, HC
    Norato, DYJ
    Schwartz, IVD
    Giugliani, R
    Burin, MG
    Sartorato, EL
    JOURNAL OF HUMAN GENETICS, 2001, 46 (03) : 146 - 149
  • [34] Estimation of Health Utility Scores for Glycogen Storage Disease Type Ia
    Eliza Kruger
    Daniel Aggio
    Hayley de Freitas
    Andrew Lloyd
    PharmacoEconomics - Open, 2023, 7 : 627 - 638
  • [35] MALLORY BODIES IN A PATIENT WITH TYPE IA GLYCOGEN-STORAGE-DISEASE
    ITOH, S
    ISHIDA, Y
    MATSUO, S
    GASTROENTEROLOGY, 1987, 92 (02) : 520 - 523
  • [36] Oxidative stress mediates nephropathy in type Ia glycogen storage disease
    Yiu, Wai Han
    Mead, Paul A.
    Jun, Hyun Sik
    Mansfield, Brian C.
    Chou, Janice Y.
    LABORATORY INVESTIGATION, 2010, 90 (04) : 620 - 629
  • [37] Liver and liver cell transplantation for glycogen storage disease type IA
    Muraca, M
    Burlina, AB
    ACTA GASTRO-ENTEROLOGICA BELGICA, 2005, 68 (04): : 469 - 472
  • [38] Bone mineral density in glycogen storage disease type Ia and Ib
    Minarich, Laurie A.
    Kirpich, Alexander
    Fiske, Laurie M.
    Weinstein, David A.
    GENETICS IN MEDICINE, 2012, 14 (08) : 737 - 741
  • [39] Characterization and pathogenesis of anemia in glycogen storage disease type Ia and Ib
    Wang, David Q.
    Carreras, Caroline T.
    Fiske, Laurie M.
    Austin, Stephanie
    Boree, Danielle
    Kishnani, Priya S.
    Weinstein, David A.
    GENETICS IN MEDICINE, 2012, 14 (09) : 795 - 799
  • [40] Increased resting energy expenditure in glycogen storage disease type Ia
    Feillet, F
    Bodamer, OAF
    Leonard, JV
    JOURNAL OF INHERITED METABOLIC DISEASE, 1998, 21 (01) : 80 - 81